Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Werner Enterprises
WERN
$2.24B
| $1.13M | ﹤0.01% |
26,776
-16
| -0.1% | -$627 |
|
1552
Seacoast Banking Corp of Florida
SBCF
$3.36B
| $1.13M | ﹤0.01% |
39,735
-65
| -0.2% | -$1.53K |
|
1553
Denali Therapeutics
DNLI
$3.65B
| $1.13M | ﹤0.01% |
52,692
-75
| -0.1% | -$1.49K |
|
1554
JFrog
FROG
$9.66B
| $1.13M | ﹤0.01% |
32,639
-55
| -0.2% | -$1.49K |
|
1555
Eastman Chemical
EMN
$8B
| $1.13M | ﹤0.01% |
12,576
-52,823
| -81% | -$4.21M |
|
1556
Bankunited
BKU
$3.37B
| $1.13M | ﹤0.01% |
34,827
-58
| -0.2% | -$1.5K |
|
1557
Axsome Therapeutics
AXSM
$11.2B
| $1.13M | ﹤0.01% |
14,187
-28
| -0.2% | -$1.87K |
|
1558
Kratos Defense & Security Solutions
KTOS
$8.74B
| $1.13M | ﹤0.01% |
55,587
-95
| -0.2% | -$1.75K |
|
1559
Crescent Energy
CRGY
$3.79B
| $1.13M | ﹤0.01% |
85,381
+34,624
| +68% | +$408K |
|
1560
Transmedics
TMDX
$2.64B
| $1.12M | ﹤0.01% |
14,197
-25
| -0.2% | -$1.51K |
|
1561
Snap
SNAP
$7.89B
| $1.12M | ﹤0.01% |
66,122
-5,937
| -8% | -$72.8K |
|
|
SEM
1562
DELISTED
Select Medical
SEM
| $1.12M | ﹤0.01% |
88,386
-188
| -0.2% | -$2.37K |
|
1563
ICF International
ICFI
$1.46B
| $1.12M | ﹤0.01% |
8,324
-14
| -0.2% | -$1.84K |
|
1564
Owens Corning
OC
$11.2B
| $1.11M | ﹤0.01% |
7,499
-29,635
| -80% | -$3.93M |
|
1565
Calix
CALX
$2.26B
| $1.11M | ﹤0.01% |
25,431
-47
| -0.2% | -$1.88K |
|
1566
Twist Bioscience
TWST
$5.7B
| $1.11M | ﹤0.01% |
30,165
+7,254
| +32% | +$168K |
|
1567
TG Therapeutics
TGTX
$7.96B
| $1.11M | ﹤0.01% |
65,026
-140
| -0.2% | -$1.63K |
|
1568
Liberty Broadband Class C
LBRDK
$4.88B
| $1.11M | ﹤0.01% |
13,778
-691
| -5% | -$58K |
|
1569
BancFirst
BANF
$3.79B
| $1.11M | ﹤0.01% |
11,360
+3,385
| +42% | +$297K |
|
1570
Highwoods Properties
HIW
$3.65B
| $1.1M | ﹤0.01% |
48,120
-82
| -0.2% | -$1.63K |
|
1571
Boston Properties
BXP
$11.2B
| $1.1M | ﹤0.01% |
15,702
-122
| -0.8% | -$7.2K |
|
1572
Pricesmart
PSMT
$5.98B
| $1.1M | ﹤0.01% |
14,540
-24
| -0.2% | -$1.7K |
|
1573
Coupang
CPNG
$29.3B
| $1.1M | ﹤0.01% |
68,045
-1,485
| -2% | -$24.5K |
|
1574
Extreme Networks
EXTR
$3.94B
| $1.1M | ﹤0.01% |
62,026
-99
| -0.2% | -$1.87K |
|
1575
Pacific Biosciences
PACB
$435M
| $1.09M | ﹤0.01% |
111,276
-120
| -0.1% | -$981 |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.